Single-Chain Fragment Variable: Recent Progress in Cancer Diagnosis and Therapy
Cancer remains a public health problem worldwide. Although conventional therapies have led to some excellent outcomes, some patients fail to respond to treatment, they have few therapeutic alternatives and a poor survival prognosis. Several strategies have been proposed to overcome this issue. The most recent approach is immunotherapy, particularly the use of recombinant antibodies and their derivatives, such as the single-chain fragment variable (scFv) containing the complete antigen-binding domains of a whole antibody that successfully targets tumor cells. This review describes the recent progress made with scFvs as a cancer diagnostic and therapeutic tool, with an emphasis on preclinical approaches and their potential use in clinical trials.
Топ-30
Журналы
|
1
2
3
|
|
|
International Immunopharmacology
3 публикации, 4.23%
|
|
|
International Journal of Molecular Sciences
3 публикации, 4.23%
|
|
|
Molecular Pharmaceutics
3 публикации, 4.23%
|
|
|
Frontiers in Immunology
3 публикации, 4.23%
|
|
|
Nature Communications
2 публикации, 2.82%
|
|
|
International Journal of Biological Macromolecules
2 публикации, 2.82%
|
|
|
International Journal of Pharmaceutics
2 публикации, 2.82%
|
|
|
Cells
1 публикация, 1.41%
|
|
|
Colloids and Surfaces A: Physicochemical and Engineering Aspects
1 публикация, 1.41%
|
|
|
Journal of Controlled Release
1 публикация, 1.41%
|
|
|
Applied Biochemistry and Biotechnology
1 публикация, 1.41%
|
|
|
Journal of Cancer Research and Clinical Oncology
1 публикация, 1.41%
|
|
|
Process Biochemistry
1 публикация, 1.41%
|
|
|
Applied Physics Reviews
1 публикация, 1.41%
|
|
|
Cancers
1 публикация, 1.41%
|
|
|
ImmunoHorizons
1 публикация, 1.41%
|
|
|
Journal of Drug Delivery Science and Technology
1 публикация, 1.41%
|
|
|
Life
1 публикация, 1.41%
|
|
|
Cell Death Discovery
1 публикация, 1.41%
|
|
|
Antibody Therapeutics
1 публикация, 1.41%
|
|
|
Molecules
1 публикация, 1.41%
|
|
|
Journal of Biological Engineering
1 публикация, 1.41%
|
|
|
Journal of Pharmaceutical Analysis
1 публикация, 1.41%
|
|
|
Biochemical Pharmacology
1 публикация, 1.41%
|
|
|
Current Protein and Peptide Science
1 публикация, 1.41%
|
|
|
Molecular Therapy
1 публикация, 1.41%
|
|
|
Scientific Reports
1 публикация, 1.41%
|
|
|
Pharmaceutics
1 публикация, 1.41%
|
|
|
Journal of Immunological Methods
1 публикация, 1.41%
|
|
|
1
2
3
|
Издатели
|
5
10
15
20
25
|
|
|
Elsevier
21 публикация, 29.58%
|
|
|
Springer Nature
16 публикаций, 22.54%
|
|
|
MDPI
9 публикаций, 12.68%
|
|
|
American Chemical Society (ACS)
6 публикаций, 8.45%
|
|
|
Frontiers Media S.A.
4 публикации, 5.63%
|
|
|
Cold Spring Harbor Laboratory
2 публикации, 2.82%
|
|
|
AIP Publishing
1 публикация, 1.41%
|
|
|
The American Association of Immunologists
1 публикация, 1.41%
|
|
|
Oxford University Press
1 публикация, 1.41%
|
|
|
Research Square Platform LLC
1 публикация, 1.41%
|
|
|
Bentham Science Publishers Ltd.
1 публикация, 1.41%
|
|
|
Autonomous Non-profit Organization Editorial Board of the journal Uspekhi Khimii
1 публикация, 1.41%
|
|
|
Taylor & Francis
1 публикация, 1.41%
|
|
|
Public Library of Science (PLoS)
1 публикация, 1.41%
|
|
|
Pleiades Publishing
1 публикация, 1.41%
|
|
|
IntechOpen
1 публикация, 1.41%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
1 публикация, 1.41%
|
|
|
Wiley
1 публикация, 1.41%
|
|
|
5
10
15
20
25
|
- Мы не учитываем публикации, у которых нет DOI.
- Статистика публикаций обновляется еженедельно.